Trial Profile
A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14c]-GDC-0941 Following Single Oral Dose Administration in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jun 2016
Price :
$35
*
At a glance
- Drugs Pictrelisib (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- Sponsors Genentech
- 22 Nov 2011 New trial record